Key Takeaway: Vanda Pharmaceuticals Inc. has announced its participation in the B. Riley Securities Mind, Muscle & Vision Summit, scheduled for July 16, 2026, in Boston, Massachusetts. This event will feature a fireside chat, showcasing Vanda's commitment to innovative therapies. The company aims to address significant medical needs and improve patient lives.
Price reaction · baseline $6.24 (2026-07-10 close) · hit after-hours · clean, no other VNDA news in the window
day 0 close · peak
-3.8%
Market Sentiment Analysis
POSITIVE FACTORS
Vanda Pharmaceuticals is actively engaging in industry events.
Participation in the summit highlights Vanda's commitment to innovation.
The company focuses on addressing high unmet medical needs.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis
Full Press Release Details
WASHINGTON,July 10, 2026/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:VNDA) today announced that the company will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston, Massachusetts on Thursday, July 16, 2026.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visitwww.vandapharma.comand follow us on X @vandapharma.